S&P 500   3,116.39 (-0.38%)
DOW   26,957.59 (-0.46%)
QQQ   216.48 (+0.52%)
AAPL   292.65 (+1.59%)
FB   197.20 (+0.22%)
MSFT   170.17 (+1.25%)
GOOGL   1,390.47 (+0.30%)
AMZN   1,979.59 (+0.35%)
CGC   19.82 (+1.02%)
NVDA   267.65 (+2.14%)
BABA   208.74 (+1.52%)
MU   52.37 (+0.52%)
GE   10.95 (-3.27%)
TSLA   778.80 (-2.64%)
AMD   47.49 (-0.17%)
T   37.10 (-0.67%)
ACB   1.51 (+0.00%)
F   7.21 (-0.28%)
NFLX   379.24 (+5.32%)
PRI   120.14 (-1.05%)
BAC   30.63 (-1.45%)
DIS   123.36 (-3.77%)
GILD   74.70 (+6.56%)
S&P 500   3,116.39 (-0.38%)
DOW   26,957.59 (-0.46%)
QQQ   216.48 (+0.52%)
AAPL   292.65 (+1.59%)
FB   197.20 (+0.22%)
MSFT   170.17 (+1.25%)
GOOGL   1,390.47 (+0.30%)
AMZN   1,979.59 (+0.35%)
CGC   19.82 (+1.02%)
NVDA   267.65 (+2.14%)
BABA   208.74 (+1.52%)
MU   52.37 (+0.52%)
GE   10.95 (-3.27%)
TSLA   778.80 (-2.64%)
AMD   47.49 (-0.17%)
T   37.10 (-0.67%)
ACB   1.51 (+0.00%)
F   7.21 (-0.28%)
NFLX   379.24 (+5.32%)
PRI   120.14 (-1.05%)
BAC   30.63 (-1.45%)
DIS   123.36 (-3.77%)
GILD   74.70 (+6.56%)
S&P 500   3,116.39 (-0.38%)
DOW   26,957.59 (-0.46%)
QQQ   216.48 (+0.52%)
AAPL   292.65 (+1.59%)
FB   197.20 (+0.22%)
MSFT   170.17 (+1.25%)
GOOGL   1,390.47 (+0.30%)
AMZN   1,979.59 (+0.35%)
CGC   19.82 (+1.02%)
NVDA   267.65 (+2.14%)
BABA   208.74 (+1.52%)
MU   52.37 (+0.52%)
GE   10.95 (-3.27%)
TSLA   778.80 (-2.64%)
AMD   47.49 (-0.17%)
T   37.10 (-0.67%)
ACB   1.51 (+0.00%)
F   7.21 (-0.28%)
NFLX   379.24 (+5.32%)
PRI   120.14 (-1.05%)
BAC   30.63 (-1.45%)
DIS   123.36 (-3.77%)
GILD   74.70 (+6.56%)
S&P 500   3,116.39 (-0.38%)
DOW   26,957.59 (-0.46%)
QQQ   216.48 (+0.52%)
AAPL   292.65 (+1.59%)
FB   197.20 (+0.22%)
MSFT   170.17 (+1.25%)
GOOGL   1,390.47 (+0.30%)
AMZN   1,979.59 (+0.35%)
CGC   19.82 (+1.02%)
NVDA   267.65 (+2.14%)
BABA   208.74 (+1.52%)
MU   52.37 (+0.52%)
GE   10.95 (-3.27%)
TSLA   778.80 (-2.64%)
AMD   47.49 (-0.17%)
T   37.10 (-0.67%)
ACB   1.51 (+0.00%)
F   7.21 (-0.28%)
NFLX   379.24 (+5.32%)
PRI   120.14 (-1.05%)
BAC   30.63 (-1.45%)
DIS   123.36 (-3.77%)
GILD   74.70 (+6.56%)
Log in

LON:SNG - Synairgen Share Price, Forecast & News

GBX 16.11
-0.99 (-5.79 %)
(As of 02/26/2020 04:00 PM ET)
Today's Range
16.11
Now: GBX 16.11
17.01
50-Day Range
6.18
MA: GBX 10.80
17.90
52-Week Range
5.50
Now: GBX 16.11
18.10
Volume199,920 shs
Average Volume78,152 shs
Market Capitalization£17.63 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Synairgen plc discovers and develops drugs for respiratory diseases. It develops inhaled interferon beta (IFN-ß), which is in Phase-II clinical trials for the treatment or prevention of asthma exacerbations caused by the common cold; IFN-ß that is in Phase-I clinical trial for the treatment or prevention of chronic obstructive pulmonary disease exacerbations caused by the common cold; and LOXL2 inhibitor, which is in Phase I clinical trial for the treatment of idiopathic pulmonary fibrosis (IPF). Read More…

Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+44-23-80512800

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales£79,000.00
Cash FlowGBX 2.97 per share
Book ValueGBX 3.90 per share

Profitability

Miscellaneous

Employees12
Market Cap£17.63 million
Next Earnings DateN/A
OptionableNot Optionable

Receive SNG News and Ratings via Email

Sign-up to receive the latest news and ratings for SNG and its competitors with MarketBeat's FREE daily newsletter.


Synairgen (LON:SNG) Frequently Asked Questions

What is Synairgen's stock symbol?

Synairgen trades on the London Stock Exchange (LON) under the ticker symbol "SNG."

Has Synairgen been receiving favorable news coverage?

Media headlines about SNG stock have trended somewhat positive on Wednesday, according to InfoTrie. InfoTrie identifies positive and negative press coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Synairgen earned a media sentiment score of 2.0 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an effect on the stock's share price in the next few days. View News Stories for Synairgen.

Who are some of Synairgen's key competitors?

What other stocks do shareholders of Synairgen own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Synairgen investors own include Yamana Gold (YRI), Polo Resources (POL), Eldorado Gold (ELD), Silvercorp Metals (SVM), Nippon Dragon Resources (NIP), Ariana Resources (AAU), Big Yellow Group (BYG), Costain Group (COST), Dekeloil Public (DKL) and Fevertree Drinks (FEVR).

Who are Synairgen's key executives?

Synairgen's management team includes the folowing people:
  • Mr. Richard Marsden, CEO, MD & Exec. Director (Age 51)
  • Mr. John Ward, Fin. Director, Company Sec. & Exec. Director (Age 57)
  • Dr. Phillip David Monk, Chairman of Scientific Advisory Board, Chief Scientific Officer & Exec. Director (Age 50)
  • Prof. Donna Davies, Co-Founder & Member of Scientific Advisory Board
  • Prof. Ratko Djukanovic, Co-Founder & Member of Scientific Advisory Board

How do I buy shares of Synairgen?

Shares of SNG and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Synairgen's stock price today?

One share of SNG stock can currently be purchased for approximately GBX 16.11.

How big of a company is Synairgen?

Synairgen has a market capitalization of £17.63 million and generates £79,000.00 in revenue each year. Synairgen employs 12 workers across the globe.View Additional Information About Synairgen.

What is Synairgen's official website?

The official website for Synairgen is http://www.synairgen.com/.

How can I contact Synairgen?

Synairgen's mailing address is Southampton General Hosp, Tremona Road, SOUTHAMPTON, SO16 6YD, United Kingdom. The company can be reached via phone at +44-23-80512800.


MarketBeat Community Rating for Synairgen (LON SNG)

Community Ranking:  1.9 out of 5 (star)
Outperform Votes:  141 (Vote Outperform)
Underperform Votes:  225 (Vote Underperform)
Total Votes:  366
MarketBeat's community ratings are surveys of what our community members think about Synairgen and other stocks. Vote "Outperform" if you believe SNG will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SNG will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/26/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel